期刊文献+

反相离子对高效液相色谱法测定人血浆中羟苯磺酸 被引量:4

RP-HPLC determination of dobesilic acid in human plasma
下载PDF
导出
摘要 目的:建立测定羟苯磺酸血浆浓度的反相离子对高效液相色谱法,并用于临床药物动力学研究。方法:0.5 mL 血浆样品经乙腈沉淀蛋白处理后,以0.05 mol·L^(-1)磷酸二氢钾缓冲液(pH 3.0)-乙腈(87:13,v/v)为流动相(流动相中含0.1%四丁基氢氧化铵),Diamonsil C_(18)柱分离,检测波长为300 nm,流速为1.0 mL·min^(-1)。结果:测定血浆中羟苯磺酸方法的线性范围为0.364~36.4 mg·L^(-1),定量下限为0.364 mg·L^(-1)。日内、日间精密度(RSD)均小于8.7%,准确度(RE)在±4.5%以内。羟苯磺酸和内标对氨基苯甲酸的平均血浆样品处理回收率分别为74.8%和94.8%。结论:该方法选择性强,操作简单,适用于羟苯磺酸钙的临床药物动力学研究。 Objective:To develop and validate a sensitive and simple reversed -phase ion -pair HPLC method for the determination of dobesilic acid in human plasma. Methods:Mter a simple protein precipitation with acetonitrile, the analyte and the internal standard ,p -aminobenzoic acid ,were chromatographied on a Diamonsil C18 column with the mobile phase consisting of 0. 05 mol ·L^-1, potassium dihydrogen phosphate buffer ( pH = 3.0) - acetonitrile (87: 13, v/v) , containing 0. 1% tetra - n - butylammonium hydroxide, at a flow rate of 1.0 mL ·min^ - 1. The UV wavelength was set at 300 nm. Results:The linear calibration curves were obtained in the range of 0. 364 -36.4 mg · L^-1. The lower limit of quantification was 0. 364 mg·L^-1. The inter -and intra -day RSD acrossed the three validation runs were both below 8.7% ,and the accuracy (RE) was within 4. 5% for the analyte. The mean recoveries of dobesilic acid and internal standard p- aminobenzoic acid were 74.8% and 94. 8% ,respectively. Conclusion:The method is proved to be special, convenient, and suitable for clinical investigation and pharmacokinetics of calcium dobesilate.
出处 《药物分析杂志》 CAS CSCD 北大核心 2007年第8期1208-1211,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 羟苯磺酸钙 高效液相色谱法 血浆药物浓度 calcium dobesilate HPLC plasma drug concentration
  • 相关文献

参考文献7

  • 1Tejerina T, Ruiz E. Calcium dobesilate: pharmacology and future approaches. Gen Pharrmacol, 1998,31 ( 3 ) :357 .
  • 2Plessas CT, Karayannakos P, Plessas ST, et al. Pharmacokinetics of calcium dobesilate in beagle dogs after a single administration. Eur J Drug Metab Pharmacokinet, 1986,11 (4) : 303 .
  • 3Franke G, Schneider T, Siegmund W, et al. Bioavailability studies of calcium dobesilate- a case of flip - flop kinetics. Pharmazie, 1985, 40:562.
  • 4卓海通,卜一珊,曹小梅,周燕,常成方,凌树森.国产羟苯磺酸钙人体生物利用度研究[J].中国临床药理学杂志,2000,16(4):295-297. 被引量:8
  • 5Rona K, Ary K. Determination of calcium dobesilate in human plasma using ion - paring extraction and high - performance liquid chromatography. J Chromatogr B,2001,755:245 .
  • 6Shah VP, Midha KK, Findlay JWA ,et al. Bioanalytical method validation : a revisit with a decade of progress. Pharm Res, 2000,17 ( 12 ) : 1551 .
  • 7Wang XJ,Jin YX,Ying JY,et al. Determination of rutin deca (H - ) sulfate sodium in rat plasma using ion - pairing solid - phase extraction. J Chromatogr B, 2006,833:231.

二级参考文献3

  • 11,Schmut O.Effect of Calcium dobesilate on the inhibition of Collagen fibrillogenesis by glucose in vitro.Arznein-Forsch Drug Res,1989;39:1555~1557.
  • 22,Schmidt M,Michal M.Inhibition of sorbitol Formation in humom erythrocytes by calcium dobesilate.Arznein-Forsch Drug Res.1989;39:493~495.
  • 33,Michal M,Gotti C.Effect of calcium dobesilate on platelet function.Thrombosis Res,1998;51:593~605.

共引文献7

同被引文献32

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部